Amphastar Pharmaceuticals Inc.

AMPH | NDAQ

Overview

ISIN(s):: US03209R1032 (+3 more)
LEI:: 54930055TH0ZLSAQMJ38
Country:: United States of America
Address:: 850 NEW BURTON ROAD, 19904 DOVER
Website:: https://amphastar.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

No description available.

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
	2025-09-03 00:00	Investor Presentation Wells Fargo Healthcare Presentation	English	3.0 MB

Automate Your Workflow. Get a real-time feed of all Amphastar Pharmaceuticals Inc. filings delivered via API.

No data available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Amphastar Pharmaceuticals Inc. via our API.

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Company	Country	Ticker
2cureX AB Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.	Sweden	2CUREX
4BASEBIO PLC Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.	United Kingdom	4BB
4SC AG Developing small-molecule epigenetic drugs for high-need cancer indications.	Germany	VSC
Abera Bioscience AB Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.	Sweden	ABERA
ABINGDON HEALTH PLC A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.	United Kingdom	ABDX
ABIONYX Pharma Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.	France	ABNX
Abliva Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.	Sweden	ABLI
AB Science Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.	France	AB
Access Bio, Inc. Develops and manufactures rapid diagnostic tests for infectious diseases for global health.	United States of America	950130
Active Biotech Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.	Sweden	ACTI